rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-4-16
|
pubmed:abstractText |
Nonselective systemic vasodilators worsen ventilation perfusion (V/Q) matching and gas exchange in patients with chronic obstructive pulmonary disease (COPD). Inhaled iloprost has the potential to act preferentially in ventilated regions of the lung, thereby reducing pulmonary hypertension (PH) while alveolar ventilation is still maintained.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0356
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
377-82
|
pubmed:meshHeading |
pubmed-meshheading:19786728-Administration, Inhalation,
pubmed-meshheading:19786728-Aged,
pubmed-meshheading:19786728-Blood Gas Analysis,
pubmed-meshheading:19786728-Exercise Tolerance,
pubmed-meshheading:19786728-Humans,
pubmed-meshheading:19786728-Hypertension, Pulmonary,
pubmed-meshheading:19786728-Iloprost,
pubmed-meshheading:19786728-Male,
pubmed-meshheading:19786728-Nebulizers and Vaporizers,
pubmed-meshheading:19786728-Oxygen Consumption,
pubmed-meshheading:19786728-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:19786728-Pulmonary Gas Exchange,
pubmed-meshheading:19786728-Vasodilator Agents
|
pubmed:year |
2010
|
pubmed:articleTitle |
Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
|
pubmed:affiliation |
University of Oklahoma Health Sciences Center, Pulmonary and Critical Care Medicine, Oklahoma City, OK 73104, USA. tarek-dernaika@ouhsc.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|